Pharmacogenetic study in rectal cancer patients treated with preoperative chemoradiotherapy: polymorphisms in thymidylate synthase, epidermal growth factor receptor, GSTP1, and DNA repair genes.

Publication Type:

Journal Article

Authors:

Páez, D; Salazar, J; Paré, L; Pertriz, L; Targarona, E; del Rio, E; Barnadas, A; Marcuello, E; Baiget, M

Source:

International journal of radiation oncology, biology, physics, Volume 81, Issue 5, p.1319-27 (2011)

URL:

http://linkinghub.elsevier.com/retrieve/pii/S0360-3016(11)00191-X

Abstract:

Several studies have been performed to evaluate the usefulness of neoadjuvant treatment using oxaliplatin and fluoropyrimidines for locally advanced rectal cancer. However, preoperative biomarkers of outcome are lacking. We studied the polymorphisms in thymidylate synthase, epidermal growth factor receptor, glutathione S-transferase pi 1 (GSTP1), and several DNA repair genes to evaluate their usefulness as pharmacogenetic markers in a cohort of 128 rectal cancer patients treated with preoperative chemoradiotherapy.

Pubmed ID: 21570215